Skip to main navigation Skip to search Skip to main content

FASCINIT: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety And Efficacy Of Denifanstat In Patients With Noncirrhotic Metabolic Dysfunction-Associated Steatohepatitis (Mash) And F2/F3 Fibrosis (Fascinate-3)

Project: Research

Project Details

StatusActive
Effective start/end date09/15/24 → 12/31/26

Funding

  • Pharmaceutical Research Associates Incorporated: $6,000.00